MARKET

LCTX

LCTX

Lineage Cell The
AMEX
1.300
-0.020
-1.52%
After Hours: 1.293 -0.007 -0.51% 17:22 05/22 EDT
OPEN
1.330
PREV CLOSE
1.320
HIGH
1.365
LOW
1.280
VOLUME
788.03K
TURNOVER
--
52 WEEK HIGH
2.090
52 WEEK LOW
0.4510
MARKET CAP
324.09M
P/E (TTM)
-4.6512
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at LCTX last week (0511-0515)?
Weekly Report · 6d ago
Analysts Offer Insights on Healthcare Companies: Tenaya Therapeutics (TNYA), Lineage Therap (LCTX) and RenovoRx (RNXT)
TipRanks · 05/15 19:30
Lineage Cell Therapeutics Q1 Earnings Call Highlights
Barchart · 05/15 18:10
Lineage Cell Therapeutics Highlights R&D Momentum Amid Losses
TipRanks · 05/14 00:12
Canaccord Genuity Reaffirms Their Buy Rating on Lineage Therap (LCTX)
TipRanks · 05/13 11:21
Analysts Offer Insights on Healthcare Companies: Nkarta (NKTX), PROCEPT BioRobotics (PRCT) and Lineage Therap (LCTX)
TipRanks · 05/13 10:50
Lineage targets operations into Q2 2028 as it launches COR1 and scales ILT1 manufacturing
Seeking Alpha · 05/13 01:52
Lineage Cell Therapeutics reports Q1 EPS (3c), consensus (2c)
TipRanks · 05/12 22:11
More
About LCTX
Lineage Cell Therapeutics, Inc. is a clinical-stage biotechnology company developing cell replacement therapies to treat serious medical conditions. The Company programs are based on a cell-based technology platform, AlloSCOPE, which develops formulation, manufacturing, and delivery capabilities, and serves as the source of its pluripotent cell-based product candidates. Its pipeline includes OpRegen, an allogeneic retinal pigment epithelial (RPE) cell replacement therapy for the treatment of geographic atrophy (GA) secondary to age-related macular degeneration (dry-AMD); OPC1, an allogeneic oligodendrocyte progenitor cell therapy for the treatment of spinal cord injuries (SCI); ReSonance (ANP1), an allogeneic auditory neuron progenitor cell transplant therapy for the treatment of auditory neuropathy; ILT1, an allogeneic cell transplant research initiative for the treatment of Type 1 Diabetes (T1D).

Webull offers Lineage Cell Therapeutics Inc stock information, including AMEX: LCTX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LCTX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading LCTX stock methods without spending real money on the virtual paper trading platform.